| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 145, Issue 10 3209-3215, Copyright © 1990 by American Association of Immunologists
ARTICLES |
M Sykes
Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
The T cell populations present in normal murine bone marrow have not been previously analyzed in detail, mainly because of their relative rarity. In order to permit such analyses, bone marrow T cells were enriched by depleting Mac1-positive cells, which constitute 65 to 90% of bone marrow cells (BMC), and then studied by two-color flow cytometry. Analysis of the remaining cells revealed that the T cell profile of adult murine bone marrow is markedly different from that of other lymphoid organs. A very high proportion of bone marrow CD3+ cells (approximately one-third) are CD4-CD8-. CD3+CD4-CD8- cells are much more concentrated among BMC T cells than among thymocytes or splenic T cells, suggesting that bone marrow may be either a site of extrathymic TCR gene rearrangement, or a major site to which such cells home from the thymus. The expression of NK1.1 was also evaluated on Mac1-depleted BMC populations. Surprisingly, up to 39% of alpha beta TCR+ BMC were found to express NK1.1. Most alpha beta TCR+NK1.1+ BMC also expressed CD4 or CD8. NK1.1+ alpha beta TCR+ cells represented a much greater proportion of BMC T cells than of other lymphoid (splenocyte or thymocyte) T cell populations. Mac1-depleted BMC of nude mice contained very few cells with this phenotype. These results are consistent with the hypothesis that NK1.1+ alpha beta TCR+ cells are generated primarily in the thymus of normal animals and migrate preferentially to bone marrow, where they may function as regulatory elements in hematopoiesis.
This article has been cited by other articles:
|
|
 |
|
  N. P. Andrews, C. D. Pack, and A. E. Lukacher Generation of Antiviral Major Histocompatibility Complex Class I-Restricted T Cells in the Absence of CD8 Coreceptors J. Virol., May 15, 2008; 82(10): 4697 - 4705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Berzofsky and M. Terabe NKT Cells in Tumor Immunity: Opposing Subsets Define a New Immunoregulatory Axis J. Immunol., March 15, 2008; 180(6): 3627 - 3635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Larkin, G. J. Renukaradhya, V. Sriram, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz CD44 Differentially Activates Mouse NK T Cells and Conventional T Cells J. Immunol., July 1, 2006; 177(1): 268 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Matsuki, A. K. Stanic, M. E. Embers, L. Van Kaer, L. Morel, and S. Joyce Genetic Dissection of V{alpha}14J{alpha}18 Natural T Cell Number and Function in Autoimmune-Prone Mice J. Immunol., June 1, 2003; 170(11): 5429 - 5437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xu, B. G. Exner, D. E. Cramer, M. K. Tanner, Y. M. Mueller, and S. T. Ildstad CD8+, {alpha}{beta}-TCR+, and {gamma}{delta}-TCR+ Cells in the Recipient Hematopoietic Environment Mediate Resistance to Engraftment of Allogeneic Donor Bone Marrow J. Immunol., February 15, 2002; 168(4): 1636 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zeng, P. Hoffmann, F. Lan, P. Huie, J. Higgins, and S. Strober Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation Blood, February 15, 2002; 99(4): 1449 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Baker, M. R. Verneris, M. Ito, J. A. Shizuru, and R. S. Negrin Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon {gamma} production Blood, May 15, 2001; 97(10): 2923 - 2931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Dang and K. D. Heyborne Cutting Edge: Regulation of Uterine NKT Cells by a Fetal Class I Molecule Other Than CD1 J. Immunol., March 15, 2001; 166(6): 3641 - 3644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-i. Seino, K. Fukao, K. Muramoto, K. Yanagisawa, Y. Takada, S. Kakuta, Y. Iwakura, L. Van Kaer, K. Takeda, T. Nakayama, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance PNAS, February 15, 2001; (2001) 41608298. [Abstract] [Full Text]
|
|
|
|
|
|
B. R. Blazar, C. J. Lees, P. J. Martin, R. J. Noelle, B. Kwon, W. Murphy, and P. A. Taylor Host T Cells Resist Graft-Versus-Host Disease Mediated by Donor Leukocyte Infusions J. Immunol., November 1, 2000; 165(9): 4901 - 4909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miyamoto, M. Emoto, V. Brinkmann, N. van Rooijen, R. Schmits, E. Kita, and S. H. E. Kaufmann Cutting Edge: Contribution of NK Cells to the Homing of Thymic CD4+NKT Cells to the Liver J. Immunol., August 15, 2000; 165(4): 1729 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Elewaut, L. Brossay, S. M. Santee, O. V. Naidenko, N. Burdin, H. De Winter, J. Matsuda, C. F. Ware, H. Cheroutre, and M. Kronenberg Membrane Lymphotoxin Is Required for the Development of Different Subpopulations of NK T Cells J. Immunol., July 15, 2000; 165(2): 671 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pied, J. Roland, A. Louise, D. Voegtle, V. Soulard, D. Mazier, and P.-A. Cazenave Liver CD4-CD8- NK1.1+ TCR{alpha}{beta} Intermediate Cells Increase During Experimental Malaria Infection and Are Able to Exhibit Inhibitory Activity Against the Parasite Liver Stage In Vitro J. Immunol., February 1, 2000; 164(3): 1463 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kaneko, M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi Augmentation of V{alpha}14 NKT Cell-mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin A-induced Hepatitis J. Exp. Med., January 3, 2000; 191(1): 105 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cui, N. Watanabe, T. Kawano, M. Yamashita, T. Kamata, C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, et al. Inhibition of T Helper Cell Type 2 Cell Differentiation and Immunoglobulin E Response by Ligand-activated V{alpha}14 Natural Killer T Cells J. Exp. Med., September 20, 1999; 190(6): 783 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Gerber, V. Azuara, J.-P. Levraud, S. Y. Huang, M.-P. Lembezat, and P. Pereira IL-4-Producing {gamma}{delta} T Cells That Express a Very Restricted TCR Repertoire Are Preferentially Localized in Liver and Spleen J. Immunol., September 15, 1999; 163(6): 3076 - 3082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yagi, U. Dianzani, H. Kato, T. Okamoto, T. Katsurada, D. Buonfiglio, T. Miyoshi-Akiyama, and T. Uchiyama Identification of a New Type of Invariant V{alpha}14+ T Cells and Responsiveness to a Superantigen, Yersinia pseudotuberculosis- Derived Mitogen J. Immunol., September 15, 1999; 163(6): 3083 - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Eberl, R. Lees, S. T. Smiley, M. Taniguchi, M. J. Grusby, and H. R. MacDonald Tissue-Specific Segregation of CD1d-Dependent and CD1d-Independent NK T Cells J. Immunol., June 1, 1999; 162(11): 6410 - 6419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Moodycliffe, S. Maiti, and S. E. Ullrich Splenic NK1.1-Negative, TCR{alpha}{beta} Intermediate CD4+ T Cells Exist in Naive NK1.1 Allelic Positive and Negative Mice, with the Capacity to Rapidly Secrete Large Amounts of IL-4 and IFN-{gamma} Upon Primary TCR Stimulation J. Immunol., May 1, 1999; 162(9): 5156 - 5163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zeng, D. Lewis, S. Dejbakhsh-Jones, F. Lan, M. Garcia-Ojeda, R. Sibley, and S. Strober Bone Marrow NK1.1- and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host Disease J. Exp. Med., April 5, 1999; 189(7): 1073 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohteki, C. Maki, S. Koyasu, T. W. Mak, and P. S. Ohashi Cutting Edge: LFA-1 Is Required for Liver NK1.1+TCR{alpha}{beta}+ Cell Development: Evidence That Liver NK1.1+TCR{alpha}{beta}+ Cells Originate from Multiple Pathways J. Immunol., April 1, 1999; 162(7): 3753 - 3756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Collins, U. E. Schaible, and S. H. E. Kaufmann Early IL-4 Induction in Bone Marrow Lymphoid Precursor Cells by Mycobacterial Lipoarabinomannan J. Immunol., November 15, 1998; 161(10): 5546 - 5554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamada, T. Ninomiya, A. Hashimoto, K. Tamada, H. Takimoto, and K. Nomoto Positive Selection of Extrathymically Developed T Cells by Self-antigens J. Exp. Med., August 17, 1998; 188(4): 779 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tamada, M. Harada, K. Abe, T. Li, and K. Nomoto IL-4-Producing NK1.1+ T Cells Are Resistant to Glucocorticoid-Induced Apoptosis: Implications for the Th1/Th2 Balance J. Immunol., August 1, 1998; 161(3): 1239 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, H. Sato, E. Kondo, M. Harada, H. Koseki, T. Nakayama, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha 14 NKT cells PNAS, May 12, 1998; 95(10): 5690 - 5693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Joyce, A. S. Woods, J. W. Yewdell, J. R. Bennink, A. D. De Silva, A. Boesteanu, S. P. Balk, R. J. Cotter, and R. R. Brutkiewicz Natural Ligand of Mouse CD1d1: Cellular Glycosylphosphatidylinositol Science, March 6, 1998; 279(5356): 1541 - 1544. [Abstract] [Full Text]
|
|
|
|
|
|
T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. CD1d-Restricted and TCR-Mediated Activation of V  14 NKT Cells by GlycosylceramidesScience, November 28, 1997; 278(5343): 1626 - 1629. [Abstract] [Full Text]
|
|
|
|
|
|
H. Yoshikawa, T. Sakihama, Y. Nakajima, and K. Tasaka Fcgamma RIII-Mediated Regulation of Hematopoiesis in Murine Bone Marrow Cells by Interleukin-3 and CD95 (Fas/Apo-1) Blood, September 1, 1997; 90(5): 1911 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Bendelac CD1: presenting unusual antigens to unusual T lymphocytes Science, July 14, 1995; 269(5221): 185 - 186. [PDF]
|
|
|
|
|
|
A Bendelac, O Lantz, M. Quimby, J. Yewdell, Bennink JR, and R. Brutkiewicz CD1 recognition by mouse NK1+ T lymphocytes Science, May 12, 1995; 268(5212): 863 - 865. [Abstract] [PDF]
|
|
|
|
|
|
A Bendelac, N Killeen, D. Littman, and R. Schwartz A subset of CD4+ thymocytes selected by MHC class I molecules Science, March 25, 1994; 263(5154): 1774 - 1778. [Abstract] [PDF]
|
|
|
|
|
|
K.-i. Seino, K. Fukao, K. Muramoto, K. Yanagisawa, Y. Takada, S. Kakuta, Y. Iwakura, L. Van Kaer, K. Takeda, T. Nakayama, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance PNAS, February 27, 2001; 98(5): 2577 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Pellicci, K. J.L. Hammond, A. P. Uldrich, A. G. Baxter, M. J. Smyth, and D. I. Godfrey A Natural Killer T (NKT) Cell Developmental Pathway Involving a Thymus-dependent NK1.1-CD4+ CD1d-dependent Precursor Stage J. Exp. Med., March 25, 2002; 195(7): 835 - 844. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
